Financials PULSION Medical Systems SE
Equities
PUS
DE0005487904
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.5 EUR | 0.00% | 0.00% | +9.38% |
Valuation
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Capitalization 1 | 193.8 | 210.9 | 186.3 | 171.5 | 179.7 | 160 |
Enterprise Value (EV) 1 | 193.5 | 210.9 | 186.3 | 171.5 | 179.7 | 160 |
P/E ratio | 63.5 x | 31.4 x | 30.2 x | 34.5 x | 19 x | 27 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.9 x | 8.25 x | 7.6 x | 6.72 x | 5.61 x | 5.72 x |
EV / Revenue | 7.89 x | 8.25 x | 7.6 x | 6.72 x | 5.61 x | 5.72 x |
EV / EBITDA | 44.1 x | 34.2 x | - | 27.1 x | 16 x | 19 x |
EV / FCF | 35.4 x | - | - | - | - | - |
FCF Yield | 2.82% | - | - | - | - | - |
Price to Book | 9.41 x | 10.2 x | 9.04 x | 8.02 x | 8.36 x | 7.09 x |
Nbr of stocks (in thousands) | 8,245 | 8,245 | 8,245 | 8,245 | 8,245 | 8,245 |
Reference price 2 | 23.50 | 25.58 | 22.60 | 20.80 | 21.80 | 19.40 |
Announcement Date | 17-04-18 | 18-04-30 | 19-04-30 | 20-05-08 | 21-06-14 | 22-05-06 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net sales 1 | 24.53 | 25.56 | 24.51 | 25.53 | 32.06 | 27.95 |
EBITDA 1 | 4.392 | 6.161 | - | 6.324 | 11.22 | 8.416 |
EBIT 1 | 3.841 | 5.61 | 6.177 | 4.807 | 9.625 | 6.163 |
Operating Margin | 15.66% | 21.95% | 25.21% | 18.82% | 30.02% | 22.05% |
Earnings before Tax (EBT) 1 | 3.198 | 7.353 | 6.23 | 4.715 | 9.776 | 6.17 |
Net income 1 | 3.051 | 6.715 | 6.167 | 4.967 | 9.451 | 5.932 |
Net margin | 12.44% | 26.27% | 25.17% | 19.45% | 29.48% | 21.22% |
EPS 2 | 0.3701 | 0.8144 | 0.7480 | 0.6024 | 1.146 | 0.7195 |
Free Cash Flow 1 | 5.46 | - | - | - | - | - |
FCF margin | 22.26% | - | - | - | - | - |
FCF Conversion (EBITDA) | 124.31% | - | - | - | - | - |
FCF Conversion (Net income) | 178.96% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 17-04-18 | 18-04-30 | 19-04-30 | 20-05-08 | 21-06-14 | 22-05-06 |
Balance Sheet Analysis
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.25 | 0 | 0 | 0 | 0 | 0 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 5.46 | - | - | - | - | - |
ROE (net income / shareholders' equity) | 14.8% | 32.6% | 29.9% | 23.7% | 44.1% | 26.9% |
ROA (Net income/ Total Assets) | 4.75% | 9.99% | 11.1% | 9.18% | 18.5% | 11.8% |
Assets 1 | 64.17 | 67.23 | 55.76 | 54.13 | 50.95 | 50.39 |
Book Value Per Share 2 | 2.500 | 2.500 | 2.500 | 2.590 | 2.610 | 2.740 |
Cash Flow per Share 2 | 0.0300 | 0 | 0 | 0 | 0 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 17-04-18 | 18-04-30 | 19-04-30 | 20-05-08 | 21-06-14 | 22-05-06 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.38% | 155M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
+13.67% | 25.02B |
- Stock Market
- Equities
- PUS Stock
- Financials PULSION Medical Systems SE